Table 1
Summary of new CMV retinitis and progression of CMV retinitis measuring response to therapy as a rise of 50 cells ×106/l over 3 months
| All patients | Responders | Non-responders | |
|---|---|---|---|
| No of patients | 63 | 34 | 29 |
| No with previous CMVR | 12 | 6 | 6 |
| No with progression of CMVR | 9 (75%) | 3 (50%) | 6 (100%) |
| No with no previous CMVR | 51 | 28 | 23 |
| No with new CMVR | 3 (6%) | 0 | 3 (11%) |
| No with progression or new CMVR | 12 (19%) | 3 (9%) | 9 (31%) |
